Y-mAbs Therapeutics, Inc.
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal anti…
Biotechnology
US, New York [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Y-mAbs Therapeutics, Inc. has no acquisition track records yet.
M&A Deals · History
Y-mAbs Therapeutics, Inc. has no acquisition track records yet.